Ildong Holdings Co Ltd (000230) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Ildong Holdings Co Ltd (000230) has a cash flow conversion efficiency ratio of 0.042x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩14.45 Billion ≈ $9.79 Million USD) by net assets (₩345.58 Billion ≈ $234.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 000230 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Ildong Holdings Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2025)
This chart illustrates how Ildong Holdings Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Ildong Holdings Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ildong Holdings Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Grupo Ezentis S.A
MC:EZE
|
-0.677x |
|
Cross Timbers Royalty Trust
NYSE:CRT
|
1.984x |
|
Tex-Ray Industrial Co Ltd
TW:1467
|
0.032x |
|
ABO Group
BR:ABO
|
0.158x |
|
BitFuFu Inc. Class A Ordinary Shares
NASDAQ:FUFU
|
0.000x |
|
Epitomee Medical Ltd
TA:EPIT
|
-0.416x |
|
Formet Celik Kapi Sanayi ve Ticaret AS
IS:FORMT
|
0.033x |
|
Iris Business Services Limited
NSE:IRIS
|
0.012x |
Annual Cash Flow Conversion Efficiency for Ildong Holdings Co Ltd (1999–2025)
The table below shows the annual cash flow conversion efficiency of Ildong Holdings Co Ltd from 1999 to 2025. For the full company profile with market capitalisation and key ratios, see Ildong Holdings Co Ltd market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩345.58 Billion ≈ $234.19 Million |
₩26.86 Billion ≈ $18.21 Million |
0.078x | +14.04% |
| 2024-12-31 | ₩254.00 Billion ≈ $172.13 Million |
₩17.31 Billion ≈ $11.73 Million |
0.068x | +120.05% |
| 2023-12-31 | ₩169.90 Billion ≈ $115.14 Million |
₩-57.77 Billion ≈ $-39.15 Million |
-0.340x | +22.91% |
| 2022-12-31 | ₩169.10 Billion ≈ $114.60 Million |
₩-74.59 Billion ≈ $-50.55 Million |
-0.441x | -164.76% |
| 2021-12-31 | ₩183.34 Billion ≈ $124.25 Million |
₩-30.54 Billion ≈ $-20.70 Million |
-0.167x | -717.76% |
| 2020-12-31 | ₩305.61 Billion ≈ $207.11 Million |
₩8.24 Billion ≈ $5.59 Million |
0.027x | -39.62% |
| 2019-12-31 | ₩321.09 Billion ≈ $217.60 Million |
₩14.34 Billion ≈ $9.72 Million |
0.045x | +18.19% |
| 2018-12-31 | ₩164.95 Billion ≈ $111.78 Million |
₩6.23 Billion ≈ $4.22 Million |
0.038x | +401.14% |
| 2017-12-31 | ₩174.64 Billion ≈ $118.35 Million |
₩-2.19 Billion ≈ $-1.49 Million |
-0.013x | -102.87% |
| 2016-12-31 | ₩106.84 Billion ≈ $72.40 Million |
₩46.64 Billion ≈ $31.61 Million |
0.437x | +172.31% |
| 2015-12-31 | ₩349.98 Billion ≈ $237.18 Million |
₩56.11 Billion ≈ $38.03 Million |
0.160x | +35.63% |
| 2014-12-31 | ₩332.95 Billion ≈ $225.64 Million |
₩39.36 Billion ≈ $26.67 Million |
0.118x | +146.72% |
| 2013-12-31 | ₩326.60 Billion ≈ $221.34 Million |
₩15.65 Billion ≈ $10.60 Million |
0.048x | -15.88% |
| 2012-12-31 | ₩324.42 Billion ≈ $219.85 Million |
₩18.48 Billion ≈ $12.52 Million |
0.057x | -65.41% |
| 2011-12-31 | ₩310.17 Billion ≈ $210.20 Million |
₩51.08 Billion ≈ $34.61 Million |
0.165x | +86.76% |
| 2010-12-31 | ₩295.00 Billion ≈ $199.92 Million |
₩26.01 Billion ≈ $17.63 Million |
0.088x | -50.51% |
| 2009-12-31 | ₩280.27 Billion ≈ $189.94 Million |
₩49.93 Billion ≈ $33.84 Million |
0.178x | +114.85% |
| 2007-12-31 | ₩195.76 Billion ≈ $132.66 Million |
₩16.23 Billion ≈ $11.00 Million |
0.083x | -60.80% |
| 2006-12-31 | ₩172.99 Billion ≈ $117.23 Million |
₩36.60 Billion ≈ $24.80 Million |
0.212x | +60.45% |
| 2005-12-31 | ₩146.78 Billion ≈ $99.47 Million |
₩19.35 Billion ≈ $13.12 Million |
0.132x | -32.30% |
| 2004-12-31 | ₩124.97 Billion ≈ $84.69 Million |
₩24.34 Billion ≈ $16.49 Million |
0.195x | +387.25% |
| 2003-12-31 | ₩105.71 Billion ≈ $71.64 Million |
₩4.23 Billion ≈ $2.86 Million |
0.040x | -73.63% |
| 2002-12-31 | ₩94.84 Billion ≈ $64.27 Million |
₩14.37 Billion ≈ $9.74 Million |
0.152x | -49.07% |
| 2001-12-31 | ₩79.37 Billion ≈ $53.79 Million |
₩23.62 Billion ≈ $16.01 Million |
0.298x | +10.87% |
| 2000-12-31 | ₩66.98 Billion ≈ $45.39 Million |
₩17.98 Billion ≈ $12.18 Million |
0.268x | +40.58% |
| 1999-12-31 | ₩55.81 Billion ≈ $37.82 Million |
₩10.66 Billion ≈ $7.22 Million |
0.191x | -- |
About Ildong Holdings Co Ltd
Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It is also involved in the… Read more